Propofol, given as an i.v. bolus for induction of anaesthesia, commonly causes hypotension which is dose related, and is less when the drug is administered slowly [1] . Propofol appears to cause more hypotension than equivalent doses of thiopentone [1] [2] [3] . This may be related to the greater decrease in peripheral vascular resistance (PVR) caused by propofol [4] . The decrease in PVR is comparable to the decrease in arterial pressure, suggesting that vasodilatation may be a major factor in propofol-induced hypotension.
Propofol, given as an i.v. bolus for induction of anaesthesia, commonly causes hypotension which is dose related, and is less when the drug is administered slowly [1] . Propofol appears to cause more hypotension than equivalent doses of thiopentone [1] [2] [3] . This may be related to the greater decrease in peripheral vascular resistance (PVR) caused by propofol [4] . The decrease in PVR is comparable to the decrease in arterial pressure, suggesting that vasodilatation may be a major factor in propofol-induced hypotension.
Other contributing factors may be a lesser increase in heart rate in response to hypotension and impairment of myocardial contractility. Propofol causes resetting of the baroceptor reflex control of heart rate without depression of baroreflex sensitivity [5] . This allows low heart rates to be sustained despite a decrease in arterial pressure. Both in patients without cardiac disease and in those with severe coronary artery disease, propofol causes about a 20 % decrease in cardiac index [6] [7] [8] which is similar to that caused by thiopentone [7] . There is evidence that propofol does not alter left ventricular performance in patients with coronary artery disease and good left ventricular function [8] . However, other studies in cardiac surgical patients suggest that the drug may cause some myocardial depression in addition to vasodilatation [7, 9] . This may be secondary to a reduction in coronary artery blood flow consequent upon hypotension [10] .
Cardiopulmonary bypass has been used as a model to study the isolated effects of drugs on the peripheral circulation [11] [12] [13] [14] . We have used this model to investigate the effect of propofol on PVR in two consecutive studies. The first study was a double-blind comparison of the effects of propofol and its vehicle on PVR. In the second study, the changes in blood concentrations of propofol were measured also.
PATIENTS AND METHODS
After informed consent had been obtained, we studied patients undergoing elective aortocoronary bypass grafting surgery. Both studies were approved by the local Ethics Committee.
Study one
Twenty-eight patients were premedicated with lorazepam 2-4 mg sublingually, 90 min before arriving in the operating theatre. Anaesthesia was induced with sufentanil 4-8 ug kg" 1 . Pancuronium 100 ug kg" 1 was given for muscle relaxation and, after intubation of the trachea, the lungs were ventilated with an oxygen-air mixture (Fi Ot = 0.5). Anaesthesia was maintained with sufentanil 0.05-0.1 ug kg" 1 min" 1 , but during cardiopulmonary bypass the infusion of sufentanil was reduced to 0.025 ug kg" 1 min"
1
. Cardiopulmonary bypass was conducted with a membrane oxygenator using non-pulsatile flow and moderate hypothermia (26-27 °C) . The circuit prime consisted of Ringer's solution 1400 ml, human albumin 200 ml and 20 % mannitol 100 ml. In all patients, systemic arterial pressure measured in a radial artery was taken to indicate perfusion pressure during cardiopulmonary bypass.
Any patient who had been given a vasoactive drug before or during cardiopulmonary bypass was excluded from the study. When nasopharyngeal temperature and pump flow had been stable for 5 min during cardiopulmonary bypass, with a perfusion pressure greater than 50 mm Hg, a bolus of 0.2 ml kg" 1 of a coded solution containing either propofol lOmgml" 1 or Intralipid was injected over 30 s into the venous inflow line of the oxygenator. Perfusion pressure, pump flow and temperature were recorded at 30-s intervals for a minimum of 10 min. Measurements were continued until cardioplegic solution was given, the pump flow was changed, or the aortic clamp was released.
Venous blood samples were withdrawn for measurement of plasma concentrations of adrenaline and noradrenaline immediately before administration of the study drug and either at the time of maximum decrease of perfusion pressure or 5 min after administration of drug. A 3-ml blood sample was placed in a cooled tube containing 60 ul of a solution of reduced glutathione eOmgml-1 and EDTA SOmgml" 1 . The samples were stored in melting ice and the plasma separated within 15 min in a refrigerated centrifuge (4 °C). Plasma was stored at -20 °C until assayed. Catecholamines were assayed radioenzymatically [15] .
Study two
This study involved 10 patients. The technique of anaesthesia and cardiopulmonary bypass and the pre-study conditions were the same as those for study one. When stable conditions had been present during cardiopulmonary bypass for 5 min, propofol 2 mg kg" 1 was injected over 30 s into the venous inflow line of the oxygenator. Perfusion pressure, pump flow and temperature were measured as described above.
Venous blood samples were withdrawn from the internal jugular vein before and 2, 4, 6, 8, 10, 20 and 30 min after injection of propofol for measurement of blood concentrations. Samples were stored at 4 °C until assayed. Propofol concentrations were measured in blood by a modification of the method described by Adam and colleagues [16, 17] .
PVR was calculated as:
perfusion pressure (mm Hg) pump flow (litre min" 1 ) x 80 dyn s cm Data were analysed by two-way analysis of variance for repeated measures. When indicated, differences within or between groups were tested using paired and unpaired t tests with Bonferroni correction for multiple comparisons. P < 0.05 was accepted as statistically significant. Results are presented as mean (SD).
RESULTS
There were no significant differences in patient data, pre-drug pump flow, perfusion pressure, Pa Oi or packed cell volume between the two groups of patients in study one, or between patients in the two studies (table I) .
Study one
Data were collected from all patients for 8 min after administration of propofol, and in 10 patients for 12.5 min. In the Intralipid group, data were collected from all patients for 6 min and from 10 patients for 8.5 min. Following administration of propofol, PVR decreased, reaching a minimum value of 1263 (283) dyn s cm" 6 at 2 min. This was 
Study two
The changes in PVR following administration of propofol were similar to those in study one (table III) .
The changes in blood concentrations of propofol for individual patients are shown in figure 2 . Initially, they decreased rapidly, presumably as a result of distribution, and then from about 6 min decreased more slowly. In all patients, blood concentrations of propofol from 8 min after administration were greater than that predicted by the pharmacokinetic model described by Gepts and colleagues [18] . DISCUSSION Haemodynamic changes after induction of anaesthesia are the result of both direct and indirect effects on the myocardium and peripheral blood vessels. The indirect effects are mediated by changes in peripheral receptors and central control mechanisms. Under normal circumstances, it may be difficult to isolate the contribution that individual mechanisms make to the overall haemodynamic response to a drug. Cardiopulmonary bypass has been shown to be a useful model for studying the isolated effects of anaesthetic drugs on PVR; it has been used to study the effect of morphine [11] , benzodiazepines [12] , droperidol [13] and thiopentone [14] . Using this model, we have found that propofol 2 mg kg" 1 , given during cardiopulmonary bypass under stable conditions of perfusion pressure, flow and temperature, caused a rapid decrease of 28% in perfusion pressure and thus of PVR. This decrease is comparable to that observed in studies when propofol was given for induction of anaesthesia. Propofol 2 mg kg" 1 given to patients undergoing elective general surgery caused a 18-22% decrease in PVR [19] . When propofol 1.5 mg kg" 1 was used to induce anaesthesia in patients undergoing elective coronary artery bypass surgery, PVR decreased by 19% [20] .
Studies of the effects of drugs on peripheral vascular tone commonly rely on estimates of vascular resistance, based on the ratio of pressure and flow (cardiac output), before and after drug administration. Valid conclusions based on these estimates depend on the assumption of a linear pressure-flow relationship that passes through the origin. This is often not the case [21] , so that isolated resistance calculations cannot discriminate between changes in pressure caused by active changes in vascular tone and passive changes resulting from altered venous return [22] . However, this does not apply to our model in which flow is independent of venous return. Furthermore, all our studies were performed during constant flow rate conditions.
In our first study, the decrease in PVR caused by propofol lasted for more than 10 min. This is in contrast to other studies, in which the reduction in PVR was of short duration. However, in those studies patients underwent laryngoscopy and intubation of the trachea within a few minutes after administration of propofol. It is possible that, had this not occurred, the decrease in PVR would have been more prolonged. A possible explanation of the prolonged reduction of PVR in our patients could be altered propofol pharmacokinetics during cardiopulmonary bypass, resulting in greater concentrations in blood than would occur after the same dose given for induction of anaesthesia. In order to investigate this, we studied the changes in concentration of propofol following a bolus injection of propofol 2 mg kg" 1 in a second group of patients. Although our results did not allow detailed pharmacokinetic analysis, they suggest that blood concentrations of propofol decreased more slowly during bypass than in patients given a similar dose of propofol for induction of anaesthesia.
It is reasonable to assume that the direct effects of propofol on vascular smooth muscle are proportional to its concentration in blood. The greater blood concentration of propofol in our patients compared with those predicted in patients not subjected to cardiopulmonary bypass, may partly explain the prolonged reduction in PVR. Cardiopulmonary bypass is known to alter significantly the disposition of many drugs as a result of haemodilution, hypotension, hypothermia and altered regional blood flow [23] . It is also possible that hypothermia (26-27 °C) may have altered the sensitivity of vascular smooth muscle to the effects of propofol. The use of non-pulsatile flow also may have contributed to the duration of the resistance decrease. Videcoq and colleagues [13] found that the decrease in vascular resistance produced by droperidol was of shorter duration with pulsatile flow.
Propofol is a weak organic acid that is bound extensively to plasma albumin, with a free fraction of only 2-3 % [24] . Haemodilution during cardiopulmonary bypass is associated with proportional decreases in the concentrations of plasma proteins, and a 1. 5-3 fold increase in the fraction of unbound propofol [25] . An increased free fraction of propofol could have contributed to the prolonged effect observed in our patients. The use of heparin during cardiopulmonary bypass causes an increase in non-esterified fatty acids because of activation of lipoprotein lipase [26] . Non-esterified fatty acids are thought to be responsible for the decrease in drug binding to plasma proteins after heparin [27] . This could be an additional explanation for our findings.
Unfortunately, because of the type of bypass circuit used in our study, we were not able to evaluate the effect of propofol on capacitance vessels. However, the finding that perfusion pressure and thus PVR decreased significantly after administration of propofol, with perfusion flow maintained constant, implies that propofol caused arteriolar vasodilatation. This could have been secondary to a reduction in sympathetic outflow caused by deepening of anaesthesia. However, the fact that catecholamine concentration did not change suggests that the haemodynamic effect of propofol was the result of direct action on blood vessels.
Although our results confirm the importance of changes in PVR to the overall haemodynamic response to propofol, they cannot be extrapolated directly to other clinical situations. Our results have been influenced by the special factors present during cardiopulmonary bypass, in particular haemodilution, hypothermia and the use of nonpulsatile blood flow. These factors should be taken into consideration when interpreting the findings of this study.
